Evidence map›Paper›PMID 19513095›Full record

ReviewEuropean journal of human genetics : EJHG2009

Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations.

Zeynep Tümer, Daniella Bach-Holm

Open access · bronzeAbstract readReview
In one paragraph

Review in European journal of human genetics : EJHG, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 2 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 2 syntheses or guidelines pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Genetic Aspects of Glaucoma: An Updated Review.Current molecular medicine · 2024
    Review
  19. Review
  20. Axenfeld-Reiger syndrome: A search for the missing links.World journal of clinical cases · 2023
    Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Zeynep TümerThe Kennedy Center, Medical Genetics Laboratory, Glostrup, Denmark. zet@kennedy.dk
Daniella Bach-Holm
Glostrup Hospital · DKKennedy Center · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant disorder, which encompasses a range of congential malformations affecting the anterior segment of the eye. ARS shows genetic heterogeneity and mutations of the two genes, PITX2 and FOXC1, are known to be associated with the pathogenesis. There are several excellent reviews dealing with the complexity of the phenotype and genotype of ARS. In this study, we will attempt to give a brief review of the clinical features and the relevant diagnostic approaches, together with a detailed review of published PITX2 and FOXC1 mutations.

Indexed as

Abnormalities, MultipleAnimalsAnterior Eye SegmentForkhead Transcription FactorsHomeobox Protein PITX2Homeodomain ProteinsHumansMutationSyndromeTranscription FactorsForkhead Transcription FactorsFOXC1 protein, humanHomeobox Protein PITX2Homeodomain ProteinsTranscription Factors

Identifiers

PMID19513095
PMCPMC2987033
OpenAlexW1992511977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.